Clinical implications of plasma hydrogen sulphide level in in Japanese people with type 2 diabete

Clinical implications of plasma hydrogen sulphide level in in Japanese people with type 2 diabete - Hydrogen Sulfide in type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020549

Enrollment

300

Registered

2016-01-13

Start date

2015-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with type 2 diabetes and patients without diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: This randomized study included randomly selected 200 patients with type 2 diabetes and 100 patients without diabetes from the outpatients who had visited this institution for type 2 diabetes and 308 outpatients without diabetes who had visited for hypertension, dyslipidemia, or thyroid disease controlled satisfactorily by medication.

Exclusion criteria

Exclusion criteria: 1) severe ketosis and diabetic coma, 2) severe complication of diabetes, 3) renal insufficiency (serum creatinine level >1.5 mg/dL in men or >1.3 mg/dL in women) and liver dysfunction, 4) severe infection, 5) pregnant or nursing women and those who might be pregnant, 6) alcoholism, and 7) any patients whom the investigators judged to be inappropriate for this study.

Design outcomes

Primary

Measure	Time frame
plasma H2S levels in patients with type 2 diabetes	—

Secondary

Measure	Time frame
The relevance between plasma H2S levels and the history of cardiovascular disease The relevance between plasma H2S levels and the glycemic control	—

Countries

Japan

Contacts

Public ContactKunihiro Suzuki

Dokkyo Medical University Department of Endocrinology and Metabolism

kuni-s@dokkyomed.ac.jp0282-86-1111

Outcome results